Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Children and Healthy Adults

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Antimicrobial Agents and Chemotherapy 2011-12, Vol.55 (12), p.5770-5779
Hauptverfasser:	DRISCOLL, Timothy A, YU, Lolie C, PING LIU, FRANGOUL, Haydar, KRANCE, Robert A, NEMECEK, Eneida, BLUMER, Jeffrey, ARRIETA, Antonio, GRAHAM, Michael L, BRADFIELD, Scott M, BARUCH, Alice
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adolescent Adult Antibiotics. Antiinfectious agents. Antiparasitic agents Antifungal Agents Antifungal Agents - administration & dosage Antifungal Agents - adverse effects Antifungal Agents - pharmacokinetics Aryl Hydrocarbon Hydroxylases - genetics Biological and medical sciences Child Child, Preschool Cytochrome P-450 CYP2C19 Dose-Response Relationship, Drug Female Genotype Humans Immunocompromised Host Immunocompromised Host - drug effects Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Infusions, Intravenous Liver Function Tests Male Medical sciences Middle Aged Pharmacology Pharmacology. Drug treatments Pyrimidines Pyrimidines - administration & dosage Pyrimidines - adverse effects Pyrimidines - pharmacokinetics Treatment Outcome Triazoles Triazoles - administration & dosage Triazoles - adverse effects Triazoles - pharmacokinetics Voriconazole Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!